BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$2.4B |
| 2 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.5B |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$1.43B |
| 4 |
Zoom
ZM
|
+$1.28B |
| 5 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$1.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.5B |
| 2 |
PPLI
People Inc
PPLI
|
+$1.26B |
| 3 |
Microsoft
MSFT
|
+$1.21B |
| 4 |
Amazon
AMZN
|
+$810M |
| 5 |
Meta Platforms (Facebook)
META
|
+$754M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.54% |
| 2 | Healthcare | 14.42% |
| 3 | Consumer Discretionary | 11.93% |
| 4 | Financials | 11.59% |
| 5 | Communication Services | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XOMA
3301
DELISTED
Xoma
XOMA
| $8.48M | ﹤0.01% |
450,217
+2,499
| +0.6% | +$46.8K |
|
|
GPX
3302
DELISTED
GP Strategies Corp.
GPX
| $8.47M | ﹤0.01% |
879,161
-31,028
| -3% | -$274K |
|
|
PSTX
3303
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $8.47M | ﹤0.01% |
+955,255
| New | +$10.9M |
|
3304
PUT
Dell
DELL
$320B
| $8.46M | ﹤0.01% |
+246,625
| New | +$7.69M |
|
3305
Genie Energy
GNE
$386M
| $8.46M | ﹤0.01% |
1,057,077
-11,066
| -1% | -$93.5K |
|
3306
Harvard Bioscience
HBIO
$30.4M
| $8.43M | ﹤0.01% |
280,236
+4,964
| +2% | +$167K |
|
|
PANA.U
3307
DELISTED
Panacea Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third
PANA.U
| $8.4M | ﹤0.01% |
+700,000
| New | +$8.06M |
|
3308
IDT Corp
IDT
$1.67B
| $8.37M | ﹤0.01% |
1,271,383
-5,109
| -0.4% | -$33.7K |
|
3309
Veru
VERU
$46M
| $8.36M | ﹤0.01% |
318,910
+13,855
| +5% | +$402K |
|
3310
iShares US & Intl High Yield Corp Bond ETF
GHYG
$199M
| $8.33M | ﹤0.01% |
+173,481
| New | +$8.36M |
|
3311
Geospace Technologies
GEOS
$66.5M
| $8.29M | ﹤0.01% |
1,341,062
-25,310
| -2% | -$173K |
|
|
STEX
3312
Streamex Corp
STEX
$90.3M
| $8.29M | ﹤0.01% |
168,080
+23,769
| +16% | +$1.76M |
|
3313
Evolution Petroleum
EPM
$135M
| $8.26M | ﹤0.01% |
3,688,110
+31,900
| +0.9% | +$84.9K |
|
|
CKPT
3314
DELISTED
Checkpoint Therapeutics
CKPT
| $8.23M | ﹤0.01% |
306,966
+73,888
| +32% | +$1.77M |
|
3315
Harrow
HROW
$1.46B
| $8.21M | ﹤0.01% |
1,469,457
-16,158
| -1% | -$96.9K |
|
3316
MVB Financial
MVBF
$397M
| $8.21M | ﹤0.01% |
514,269
-36,217
| -7% | -$513K |
|
3317
iShares Global Materials ETF
MXI
$356M
| $8.2M | ﹤0.01% |
+117,316
| New | +$8.07M |
|
|
FONR
3318
DELISTED
Fonar
FONR
| $8.19M | ﹤0.01% |
392,357
-2,825
| -0.7% | -$68.1K |
|
3319
Schwab Emerging Markets Equity ETF
SCHE
$12.9B
| $8.16M | ﹤0.01% |
305,079
-21,500
| -7% | -$574K |
|
3320
Icon
ICLR
$12.9B
| $8.16M | ﹤0.01% |
42,720
-10,836
| -20% | -$1.99M |
|
3321
Prospect Capital
PSEC
$1.18B
| $8.14M | ﹤0.01% |
1,618,063
-194,523
| -11% | -$978K |
|
3322
Mirum Pharmaceuticals
MIRM
$6.02B
| $8.13M | ﹤0.01% |
421,969
-3,569
| -0.8% | -$76.6K |
|
3323
NI Holdings
NODK
$313M
| $8.13M | ﹤0.01% |
481,211
-43,774
| -8% | -$704K |
|
3324
iShares iBonds Dec 2029 Term Corporate ETF
IBDU
$4.07B
| $8.12M | ﹤0.01% |
300,045
| – | – |
|
|
TIG
3325
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
| $8.11M | ﹤0.01% |
+531,704
| New | +$8.11M |
|
Similar funds
BlackRock's Q3 2020 Portfolio in Review
As of Q3 2020, BlackRock held 5,280 positions worth $2.71T, up 8.2% from $2.51T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q3 2020 filing shows 239 new, 1,746 increased, 2,572 reduced and 207 closed positions. Its largest new stake was Dun & Bradstreet: 31,290,496 shares worth $803M. The largest sale was Apple, an estimated $3.5B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- BlackRock's largest Q3 2020 buy was Dun & Bradstreet: 31,290,496 shares worth $803M.
- BlackRock added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q3 2020, an estimated $2.4B increase.
- BlackRock's biggest Q3 2020 reduction was Apple, cutting an estimated $3.5B.
- BlackRock fully exited Caesars Entertainment Corporation in Q3 2020, selling an estimated $633M.
- BlackRock's ten largest holdings make up 19% of its $2.71T portfolio in Q3 2020.
- BlackRock opened 239 new positions and closed 207 in Q3 2020.
- BlackRock's portfolio value rose 8.2% quarter-over-quarter to $2.71T.
Based on BlackRock's 13F filing for Q3 2020, filed 6 Nov 2020.